Evidence map›Paper›PMID 34367179›Full record

ArticleFrontiers in immunology2021

Involvement of Innate Immune Receptors in the Resolution of Acute Hepatitis B in Woodchucks.

Manasa Suresh, Bin Li, Marta G Murreddu, Severin O Gudima, Stephan Menne

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Manasa SureshDepartment of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC, United States.
Bin LiDepartment of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC, United States.
Marta G MurredduDepartment of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC, United States.
Severin O GudimaDepartment of Microbiology, Molecular Genetics & Immunology, University of Kansas Medical Center, Kansas City, KS, United States.
Stephan MenneDepartment of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC, United States.
Georgetown University · USGeorgetown University Medical Center · USUniversity of Kansas Medical Center · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
Super-infection and virus spread during chronic hepadnaviral infectionR01CA166213 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI GUDIMA, SEVERIN O, MENNE, STEPHAN · 2012 to 2016
$1.6M
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA166213
6 · The paper itself

Abstract

The antiviral property of small agonist compounds activating pattern recognition receptors (PRRs), including toll-like and RIG-I receptors, have been preclinically evaluated and are currently tested in clinical trials against chronic hepatitis B (CHB). The involvement of other PRRs in modulating hepatitis B virus infection is less known. Thus, woodchucks with resolving acute hepatitis B (AHB) after infection with woodchuck hepatitis virus (WHV) were characterized as animals with normal or delayed resolution based on their kinetics of viremia and antigenemia, and the presence and expression of various PRRs were determined in both outcomes. While PRR expression was unchanged immediately after infection, most receptors were strongly upregulated during resolution in liver but not in blood. Besides well-known PRRs, including TLR7/8/9 and RIG-I, other less-characterized receptors, such as IFI16, ZBP1/DAI, AIM2, and NLRP3, displayed comparable or even higher expression. Compared to normal resolution, a 3-4-week lag in peak receptor expression and WHV-specific B- and T-cell responses were noted during delayed resolution. This suggested that PRR upregulation in woodchuck liver occurs when the mounting WHV replication reaches a certain level, and that multiple receptors are involved in the subsequent induction of antiviral immune responses. Liver enzyme elevations occurred early during normal resolution, indicating a faster induction of cytolytic mechanisms than in delayed resolution, and correlated with an increased expression of NK-cell and CD8 markers and cytolytic effector molecules. The peak liver enzyme level, however, was lower during delayed resolution, but hepatic inflammation was more pronounced and associated with a higher expression of cytolytic markers. Further comparison of PRR expression revealed that most receptors were significantly reduced in woodchucks with established and progressing CHB, and several RNA sensors more so than DNA sensors. This correlated with a lower expression of receptor adaptor and effector molecules, suggesting that persistent, high-level WHV replication interferes with PRR activation and is associated with a diminished antiviral immunity based on the reduced expression of immune cell markers, and absent WHV-specific B- and T-cell responses. Overall, the differential expression of PRRs during resolution and persistence of WHV infection emphasizes their importance in the ultimate viral control during AHB that is impaired during CHB.

Indexed as

Immunity, InnateAnimalsBiomarkersDisease ProgressionGene ExpressionHepatitis BHepatitis B, ChronicHepatitis B Virus, WoodchuckInflammasomesLiverMarmotaReceptors, ImmunologicTranscription FactorsViral LoadBiomarkersInflammasomesReceptors, ImmunologicTranscription Factorsacute hepatitis Bchronic hepatitis Bhepatitis B virusinnate immune responsepattern recognition receptorswoodchuck

Identifiers

PMID34367179
PMCPMC8340647
OpenAlexW3184788597

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.